OPEL Technologies Creates Advisory Board to

New Post Public Reply Private Reply Replies (0) Message Board
sevenOdouble

OPEL Technologies Creates Advisory Board to Special Strategic Committee



OPEL Technologies Inc. (TSX VENTURE:OPL)(OTCQX:OPELF) ("OPEL" or "the Company")
today announces appointments to the Special Strategic Committee (SSC) and its
Advisory Board. As announced on June 10, the Company formed the SSC which is
chaired by Executive Director, Peter Copetti, and which was given the mandate to
evaluate strategic alternatives in relation to the sale or licensing of the
Company's proprietary POET platform, to deliver recommendations to the Board,
and to carry out any selected transactions to completion as confirmed by the
Board. 


Mr. Copetti is pleased to announce that Dr. Adam Chowaniec, a director of the
Company, has been appointed to serve on the SSC and that Lee Shepherd, Martin
Peisl and Geoffrey C. Rogers have been appointed to serve on the SSC's Advisory
Board. 


Mr. Rogers has over 30 years of experience in high-performance semiconductors,
EDA software, and intellectual property licensing. Having earned a BSEE from
Cornell University, Mr. Rogers has held key roles with Tensilica (now Cadence
Design Systems, Inc. - NASDAQ: CDNS), Silicon Architects (now Synopsys, Inc. -
NASDAQ: SNPS), VLSI Technology (became Philips Semiconductor) and Applied Micro
Circuits Corp. - NASDAQ: AMCC. 


Dr. Martin Peisl has over 33 years of management experience in Semiconductor
research, development and marketing. He has served companies such as Siemens,
Infineon, Qimonda, Ramaxel, and Netlist. His people and project management
background includes broad international experience in Germany, Malaysia, France,
China and the U.S. Dr. Peisl was directly responsible for product development of
Dynamic Random Access Memory (DRAM) generations from 64Mbit to 1Gbit.
Additionally, he has supervised starting new product lines such as Mobile Random
Access Memory, Reduced Latency DRAM and DRAM based Application Specific
Integrated Circuits (ASICS). Being a decade long member of the Joint Electron
Device Engineering Council (JEDEC) standardization committee, Dr. Peisl has
chaired the development of the predecessor of the Double Data Rate 2 (DDR2)
specification within the Advanced DRAM Technology (ADT) consortium together with
technical members of Intel, Samsung, Hynix, Micron and Elpida. 


"Messrs. Peisl and Rogers will be valuable members of the SSC Advisory Board"
stated Mr. Copetti "and I look forward to working with them along with Dr.
Chowaniec and Lee Shepherd, VP of Technology." 


The directors have accepted the recommendations of the Compensation Committee
and granted, to Messrs. Peisl, Rogers, Chowaniec and Shepherd, incentive stock
options to purchase an aggregate of 1,200,000 common shares, representing 0.9%
of the outstanding shares of the Company. The stock options are exercisable at a
price per share of CA$0.46 and expire on June 27, 2018. The exercise price was
the closing price on the day prior to the grant, being June 26, 2013. 


Prior to the option grant, there were 18,224,000 options outstanding and
132,474,865 voting shares outstanding. The Company's Stock Plan provides for a
vesting schedule of 25% upon grant and 25% every six months thereafter, subject
to modification by the directors based on performance. These options were
granted subject to provisions of the Company's stock option plan which was
approved by shareholders at the annual and special shareholders meeting on June
21, 2013, and are subject to the TSX Venture Exchange policies and the
applicable securities laws. 


About OPEL Technologies Inc. 

OPEL is the developer of the POET platform for monolithic fabrication of
integrated circuit devices containing both electronic and optical elements on a
single semiconductor wafer. With head office in Toronto, Ontario, Canada, and
operations in Storrs, CT, the Company, through ODIS Inc., a U.S. company,
designs III-V semiconductor devices for military, industrial and commercial
applications, including infrared sensor arrays and ultra-low-power random access
memory; and through OPEL Solar, Inc., provided systems for energy applications.
The Company has 32 patents issued and 6 patents pending, primarily for its
semiconductor POET process, which enables the monolithic fabrication of
integrated circuits containing both electronic and optical elements, with
potential high speed and power-efficient applications in devices such as
servers, tablet computers and smartphones. OPEL's common shares trade on the TSX
Venture Exchange under the symbol "OPL" and on the OTCQX under the symbol
"OPELF". For more information please visit our websites at www.opeltechinc.com
and for ODIS at www.odisinc.com.


ON BEHALF OF THE BOARD OF DIRECTORS

Michel Lafrance, Secretary

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts responsibility
for the adequacy or accuracy of this release.

FOR FURTHER INFORMATION PLEASE CONTACT: 
Grayling
Christopher Chu
(646) 284-9426
opel@grayling.com

POET Technologies Inc. (POET) Stock Research Links

POET Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PPL Reports Strong Q3; Long-Term EPS Growth Up

Updated Category News Views 29

Solid Earnings in a Challenging Market Anytime you start hearing a company like PPL boasting about their quarterly earnings, it's time to sit up straight and pay attention. The utility giant didn’t just match expectations, they beat 'em, clocking in with $0.54 per share in ongoing earnings for Q3 2026, up from $0.48 the previous year. Not a bad step forward if you ask...

Continue Reading
Thryfter Unleashes Livestream Magic at Goodwill Event

Updated Category News Views 89

A Dynamic Shift in Thrift Shopping All eyes might be on Thryfter this November as they drop some serious retail knowledge at the Goodwill CONNECT Conference in Houston. We’re talking about a tech shake-up for Goodwill’s model, thanks to Thryfter's livestream shopping craze that’s poised to weld traditional thrifting with digital reach. The Power of Virtual Thrift...

Continue Reading
RCMA Makeup Makes Bold Retail Move with Ulta.com Debut

Updated Category News Views 25

RCMA Makeup: A Longstanding Industry Insider You know when a brand’s been around the block since the 60s, it’s got staying power. RCMA Makeup’s been a snug fit in the toolbox of professional makeup artists for over six decades. This ain't some fly-by-night operation. They’ve thrived on word of mouth—no flashy ads or promotional stunts. Just rock-solid reputation...

Continue Reading
Encompass Health Faces Uncertain Future with Sea Pines

Updated Category News Views 68

Unexpected Downpour Closes Sea Pines They say when it rains, it pours. That's not just true in life, but as it happens, it's quite literal in Melbourne, Florida. A deluge of biblical proportions forced an immediate lockdown of the Sea Pines Rehabilitation Hospital. Flooded to the gills, this once stalwart institution finds its doors shuttered indefinitely. It's a...

Continue Reading
Home Insurance Depreciation and What it Means for You

Updated Category News Views 17

A Deep Dive into Depreciation's Impact on Home Insurance Folks, if you haven't battled the insurance beast, you're missing out on an unholy mess. Let's talk about something that's been quietly gnawing at homeowners’ wallets—depreciation in home insurance claims. Peggy Schneider, an insurance guru from Kalispell, Montana, lays it all out in HelloNation, and I'm here to...

Continue Reading
CMS 2027 Fee Schedule: Game Changer for SI Joint Procedures

Updated Category News Views 145

CMS's Move: A New Payment Pathway You don't expect bureaucrats to stir things up, but check this out: the CMS 2027 Physician Fee Schedule has done just that by setting a non-facility (office) payment rate for CPT code 27279. This code covers those fiddly, minimally invasive sacroiliac (SI) joint procedures, where you engage bone and get down to real orthopedic business....

Continue Reading
Koozee Boosts Apparel Design with AI Workflows

Updated Category News Views 108

Revolutionizing Apparel Design with AI If you've ever wondered how tech can make an impact on the fashion world, Koozee's latest update provides an eye-opening look. This isn't about following trends—it's about setting them, and Koozee’s making a bold move with its newest platform enhancements. Introducing Freeform Canvas Koozee has launched the Freeform Canvas, a...

Continue Reading
Strategies for Maintaining Water Quality in NH Homes

Updated Category News Views 92

Protect Your Water: Steps to Safe Drinking Imagine turning on your kitchen tap, and instead of refreshing, clean water, you get a murky mystery. Not exactly anyone's dream scenario, right? Enter Sean McGorry and his down-to-earth guide to water quality for New Hampshire homesteaders. It's not rocket science, but the whispers of neglected water systems tell tales of...

Continue Reading
Upright Proton Therapy: New Era for Cancer Care

Updated Category News Views 129

BayCare's Bold Step into Upright Proton Therapy Here's a twist for you—BayCare Health System has rolled out something that's genuinely pushing the envelope in cancer treatment. They've treated their first patient with an upright proton therapy system. Now, talk about innovation that shakes things up. This isn't just any old upgrade; it's a complete revamp of how proton...

Continue Reading
SM Investments Wins Five Golden Arrows: Governance on Point

Updated Category News Views 82

Gold Arrows and Golden Standards What’s in a bunch of gold arrows, you might ask? Well, for SM Investments Corporation, those Five Golden Arrows from the Institute of Corporate Directors aren't just shiny trinkets. They're badges of honor, symbols of a rock-solid governance fortress. For the third year running, they’ve nailed the top spot under the corporate...

Continue Reading

Top 5 Most Recently Viewed Articles

Yale School of Medicine Celebrates Achievements in Research

Updated Category News Views 167

Yale School of Medicine Celebrates Achievements in Research Today, twenty-seven distinguished faculty members from Yale School of Medicine (YSM) were honored for their remarkable contributions to the field of medical research. Recognized as Highly Cited Researchers for the year 2025, these experts are acknowledged for their influential studies that have garnered...

Continue Reading
Saothair Capital Partners Strengthens Portfolio with T BAILEY

Updated Category News Views 399

Saothair Capital Partners Acquires Majority Stake in T BAILEY In a strategic move, Saothair Capital Partners, LLC has completed the acquisition of a majority equity stake in T BAILEY, LLC. This acquisition signals Saothair's commitment to investing in the middle-market manufacturing sector. Known for its extensive experience and focus, Saothair aims to enhance T BAILEY's...

Continue Reading
Semtech's Earnings Report: What to Anticipate This Quarter

Updated Category News Views 114

Semtech's Earnings Report: What Investors Should Expect Semtech (NASDAQ: SMTC) is gearing up to release its latest quarterly earnings report shortly. As anticipation builds, it's crucial for investors to stay informed on what this means for their holdings in the company. Analysts have projected that Semtech will deliver an earnings per share (EPS) of $0.23. Investors are...

Continue Reading
Vistra Energy Faces Challenges After Battery Facility Fire

Updated Category News Views 192

Vistra Energy Stock Takes a Hit Due to Facility Incident Shares of Vistra Energy (NYSE: VST) experienced a decline of 1.4% in early trading today, following reports of a significant fire at a battery facility located at the company’s Moss Landing power plant. This facility, situated in Monterey County, was put into emergency lockdown as authorities evacuated surrounding...

Continue Reading
Compass Therapeutics Elevates Growth with $120 Million Offering

Updated Category News Views 186

Compass Therapeutics Unveils Significant Public Offering Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a dedicated clinical-stage biopharmaceutical company focused on oncology, has excitedly announced the pricing of an upsized public offering. This offering includes 33,290,000 shares of common stock priced at $3.00 each, along with pre-funded warrants for...

Continue Reading